Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “bupivacaine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 47
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 47 pipeline programs matching "bupivacaine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

47 results for “bupivacaine” Back to intelligence hub

Search results

Page 1 of 2
  1. Bupivacaine

    Pacira Ireland Limited

    Malignant Neoplasms of Female Genital Organs

    phase 3 small molecule terminated

    1 trial
  2. Bupivacaine

    United Therapeutics Europe Ltd

    Postoperative Pain

    phase 3 small molecule active

    1 trial
  3. Bupivacaine HCl

    Pacira Ireland Limited

    Hemorrhoids

    phase 3 small molecule completed

    1 trial
  4. Bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain

    phase 3 small molecule completed

    3 trials
  5. Bupivacaine Liposome Injection

    United Therapeutics Europe Ltd

    Osteoarthritis

    phase 3 small molecule terminated

    1 trial
  6. Bupivacaine liposome

    Pacira Ireland Limited

    Dental Pain

    phase 3 small molecule completed

    1 trial
  7. Bupivacaine liposome injectable suspension 266 mg

    Pacira Ireland Limited

    Bunionectomy

    phase 3 small molecule completed

    1 trial
  8. Liposomal bupivacaine

    Pacira Ireland Limited

    Surgery

    phase 3 small molecule completed

    1 trial
  9. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Pain

    phase 3 small molecule completed

    2 trials
  10. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Pain, Postoperative

    phase 3 small molecule active

    1 trial
  11. bupivacaine liposome injectable suspension

    Pacira Ireland Limited

    Knee Osteoarthritis

    phase 3 small molecule completed

    1 trial
  12. Bupivacaine HCI without epinephrine

    Heron Therapeutics

    Post-Operative Pain

    phase 2 small molecule completed

    1 trial
  13. Liposomal Bupivacaine

    United Therapeutics Europe Ltd

    Femoral Fractures

    phase 2 small molecule terminated

    1 trial
  14. Liposomal bupivacaine

    United Therapeutics Europe Ltd

    Blunt Chest Wall Trauma

    phase 2 small molecule completed

    1 trial
  15. Liposome bupivacaine

    Pacira Ireland Limited

    Hallux Valgus (Bunions)

    phase 2 small molecule completed

    1 trial
  16. Liposome bupivacaine + bupivacaine

    Pacira Ireland Limited

    Dupuytren's Contracture of the Hand (Viking's Disease)

    phase 2 small molecule completed

    1 trial
  17. SKY0402 + bupivacaine HCl

    Pacira Ireland Limited

    Postoperative Pain

    phase 2 small molecule completed

    1 trial
  18. Bupivacaine alone OR Bupivacaine-Ketorolac-Ketamine (BKK) Combination

    Rhythm Pharmaceuticals Netherlands B.V.

    Pain Management

    phase 1 small molecule active

    1 trial
  19. Liposomal Bupivacaine 13.3

    Pacira Ireland Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  20. Liposomal bupivacaine

    United Therapeutics Europe Ltd

    Pain, Postoperative

    phase 1 small molecule completed

    1 trial
  21. 0.1% bupivacaine

    United Therapeutics Europe Ltd

    Pregnancy

    approved small molecule active

    1 trial
  22. Bupivacaine

    Hospital Authority, Hong Kong

    Pain

    approved small molecule completed

    1 trial
  23. Bupivacaine

    United Therapeutics Europe Ltd

    Amputation Stumps

    approved small molecule completed

    1 trial
  24. Bupivacaine FNB

    Pacira Ireland Limited

    Pain

    approved small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.